# A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients

> **NCT06237777** · PHASE1 · UNKNOWN · sponsor: **Wang Min** · enrollment: 18 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **GENETIC:** SKG0106 intravitreal injection dose level 1, 2 or 3

## Key facts

- **NCT ID:** NCT06237777
- **Lead sponsor:** Wang Min
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237777, "A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06237777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*